So far, the tumor immune microenvironment (TIME) of HER2-positive BC remains poorly characterized and existing data usually comprise pooled analyses of hormone receptor (HR)-positive and HR-negative HER2-positive tumors6. Here, NR4A1 is linked to breast cancer.